Chronic hepatitis B virus (HBV) infection affects 250 million persons worldwide and is the most important cause of liver cirrhosis and cancer. In 2017, the World Health Organization outlined specific targets along the prevention and care cascade to be met if the elimination of HBV as a global health threat was to be achieved. Among the proposed core interventions, global service coverage of the HBV vaccine birth dose, as well as the uptake of testing and antiviral therapy remain largely insufficient. This presentation will highlight the key determinants of global HBV elimination and discuss the main challenges that will be faced during the implementation of prevention and care interventions. It will also insist on the importance of addressing logistic and sociocultural barriers, especially in resource-limited countries where the HBV burden is highest. As many of the challenges expected to arise on the road to HBV elimination are similar to those experienced during the fight against HIV, it will be critical to learn the lessons from the past 30 years and avoid making the same mistakes. Recent improvements in the understanding of the HBV life cycle and the development of promising treatment modalities to achieve the functional cure of HBV have helped move HBV elimination up the global political agenda. However, HBV elimination will only be achieved if these scientific achievements are accompanied by the rapid uptake of HBV vaccination, testing and treatment. To succeed, HBV elimination efforts will heavily rely on innovative public health strategies, education and political will.